Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyperAcute Breast Cancer Vaccine in Relapsed/Refractory Breast Cancer
NCT00090480Phase 2Terminated
- Sponsor
- Lumos Pharma, Inc.
- Start
- Aug 2004
- Primary completion
- Sep 2007
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of HyperAcute-Breast in breast cancer, sponsored by Lumos Pharma, Inc.. Started Aug 2004; status: terminated.
02
Drugs
HyperAcute-Breast
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00090480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090480.